Public and investor relations for the innovators in healthcare and technology

We’ve been delivering measurable PR and IR results for innovative companies in health and technology since our founding more than 30 years ago originally as Noonan/Russo Communications.  When it comes to raising awareness of your company and product as well as forging new relationships, no one connects you to the people you want to know like we do. Our team of PhD-level scientists, former journalists, TV producers, and Wall Street professionals is on a first-name basis with the who’s who in media, finance, medicine and technology.

L-Glutamine Therapy Making Strides in Diabetes Treatment
| PharmaTech Outlook

CEO and Chairman of Emmaus Life Sciences, Dr. Yutaka Niihara, discusses expanding the application of pharmaceutical-grade L-glutamine (PGLG) as a therapeutic for sickle cell disease to investigating its potential in treating type II diabetes. Emmaus is set to conduct a clinical study in collaboration with the Straub Medical Center to explore the role of PGLG in […]

read more
FSD Pharma Closes Prismic Pharma Acquisition: ‘A Paradigm Shift In The Overall Outlook Of The Company’
| Benzinga

FSD Pharma Inc. announced this week it closed a deal to acquire Prismic Pharmaceuticals, a U.S.-based specialty pharmaceutical company dedicated to addressing the opioid crisis. Through the utilization of its micro-PEA platform, the company seeks to develop novel, non-addictive prescription drugs. Such formulations impact the endocannabinoid system. This means that lower doses of drugs can be used […]

read more
Telemedicine apps are thriving because working moms love the convenience of their smartphones

When Laika Kayani started to lose her voice late one night last year, she picked up her iPhone and got connected to a doctor through a video-chat service called American Well. Kayani, who works at a health-tech company in San Francisco, used the app because her young son and husband were asleep and there were no […]

read more